Atria Wealth Solutions, Inc. Astrazeneca PLC Transaction History
Atria Wealth Solutions, Inc.
- $8.74 Billion
- Q4 2024
A detailed history of Atria Wealth Solutions, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Atria Wealth Solutions, Inc. holds 50,035 shares of AZN stock, worth $3.79 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
50,035
Previous 43,065
16.18%
Holding current value
$3.79 Million
Previous $3.36 Million
2.3%
% of portfolio
0.04%
Previous 0.04%
Shares
16 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.57 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.1 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.84 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.8 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.82 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $234B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...